SK Biopharmaceuticals Co. Ltd Financials

Market Capitalization ₩7.338 Trillion as of July 1, 2025

Valuations Metrics as of Jul. 4, 2025

Trailing PE
Forward PE	26.17
Price to Sales TTM	₩12.70
Price to Book MRQ	₩
Enterprise to Revenue	12.26
Enterprise to EBITDA	54.75

Financial Reports as of Mar. 31, 2025

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2025-03-31
Profit Margin	43.46%
Operating Margin	17.78%
Return on Assets TTM	7.79%
Return on Equity TTM	50.86%

Income Statement

Revenue TTM	₩577,998,815,232
Revenue per Share TTM	₩7380.60
Quarterly Revenue Growth	26.70%
Gross Profit TTM	₩536,345,018,368
EBITDA	₩226,699,263,310
Net Income to Common TTM	₩251,210,579,968
Diluted EPS TTM	₩
Quarterly Earnings Growth YoY	81.60%

Balance Sheet

Total Cash MRQ	₩268,694,634,496
Total Cash per Share MRQ	₩3431.02
Total Debt MRQ	₩
Total Debt to Equity MRQ	21.08
Current Ratio MRQ	1.84
Book Value per Share MRQ	₩

Cash Flow

Operating Cash Flow TTM	₩99,766,591,488
Levered Free Cash Flow TTM	₩40,085,725,184

326030 Stock Info as of Jul. 4, 2025

Stock Statistics

Shares Outstanding	78,313,250
Float Shares	28,059,637
Avg 10 Volume	163,730
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	64.18%
% Held by Institutions	13.61%

Stock Price Summary

Beta	0.89
Fifty Two Week Low	₩72600.00
Fifty Two Week High	₩130000.00
Fifty Two Week Change	12.58%
Day 50 MA	₩94750.00
Day 200 MA	₩105763.00

Dividends and Splits

Forward Annual Dividend Rate	₩
Forward Annual Dividend Yield	%
Trailing Annual Dividend Rate	₩
Trailing Annual Dividend Yield	%
Payout Ratio	0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date